About Medmo
Medmo is a private company based in New York, New York. It has reported $31,847,080 raised in ten offerings on Form D since December 2017. Its chief executive is Lucas Takahashi.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 6, 2025 | Oct 14, 2025 | $14,621,048fully sold | 12 | $1.2M | EquityRule 506(b) | Form D ↗ |
| Dec 20, 2024 | Feb 18, 2025 | $4,621,050of $5.0M target | 11 | $420K | OptionsRule 506(b) | Form D ↗ |
| Oct 11, 2023 | Oct 26, 2023 | $4,999,982fully sold | 13 | $384K | EquityRule 506(b) | Form D ↗ |
| Jul 26, 2022 | Aug 10, 2022 | $1,610,000of $4.0M target | 12 | $134K | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 2, 2021 | Aug 11, 2021 | $2,700,000fully sold | 3 | $900K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 22, 2020 | Jan 4, 2021 | $3,000,000of $4.0M target | 1 | $3.0M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 4, 2019 | Sep 18, 2019 | $70,000of $1.0M target | 2 | $35,000 | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Apr 16, 2018 | May 1, 2018 | $150,000fully sold | 2 | $75,000 | EquityRule 506(b) | Form D ↗ |
| Jan 27, 2018 | Feb 7, 2018 | $25,000fully sold | 2 | $12,500 | EquityRule 506(b) | Form D ↗ |
| Nov 30, 2017 | Dec 15, 2017 | $50,000fully sold | 1 | $50,000 | EquityRule 506(b) | Form D ↗ |
| Total, ten offerings | $31,847,080 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Medmo's Form D filed Oct 14, 2025.
LT
GP
Gadi Porat
Director
RE
Robert Epstein
Director
CK
Christopher Kelly
Director
Earlier filings also listed Alex Dikman (director, last listed Aug 2021).